Exosens (FRA:H8Y)
Germany
· Delayed Price · Currency is EUR 40.00
-1.25 (-3.03%)
At close: Jun 27, 2025, 10:00 PM CET
Exosens Revenue
In the year 2024, Exosens had annual revenue of 394.08M EUR with 35.04% growth. Exosens had revenue of 207.18M in the half year ending December 31, 2024.
Revenue
394.08M
Revenue Growth
+35.04%
P/S Ratio
5.49
Revenue / Employee
301.28K
Employees
1,401
Market Cap
2.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394.08M | 102.26M | 35.04% |
| Dec 31, 2023 | 291.82M | 91.07M | 45.36% |
| Dec 31, 2022 | 200.75M | 34.58M | 20.81% |
| Dec 31, 2021 | 166.17M | 16.31M | 10.88% |
| Dec 31, 2020 | 149.86M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Rheinmetall AG | 10.48B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Siemens Energy AG | 37.44B |
| Siemens Healthineers AG | 23.14B |